04Mar/13

India board rules against Bayer in cancer drug patent case – Reuters


The National Law Journal

India board rules against Bayer in cancer drug patent case
Reuters
Announcing the decision, Justice Prabha Sridevan said the kidney and liver cancer drug should be available at an affordable price to everybody. Bayer said in a statement it “strongly disagreed” with the conclusions of the board, adding that it would
India Patent Ruling on Cancer Drug a Blow to Bayer AGThe National Law Journal
India Appeals Body Rejects Bayer’s Plea on NexavarWall Street Journal (India)
Bayer to Appeal India Ruling That Allows Copy of Cancer DrugBloomberg
Economic Times –Intellectual Property Watch –MSF UK (press release)
all 19 news articles »
04Mar/13

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market … – PR Newswire (press release)

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market
PR Newswire (press release)
GBI Research, the leading business intelligence provider, has released its latest research, “Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion”.

and more »

04Mar/13

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market … – MarketWatch (press release)

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market
MarketWatch (press release)
GBI Research, the leading business intelligence provider, has released its latest research, “Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion”.

and more »